TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Time to serum [MTX] < 0.1 µM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute kidney injury biomarkers
Endpoint domain: Adverse events/effects
Primary endpoint: skin dimpling improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: short-term functional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of screw loosening
Endpoint domain: Adverse events/effects
Primary endpoint: Confidence going into surgery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in acne appearance (ECCA per cent reduction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Occurrences of treatment-related side-effects
Endpoint domain: Adverse events/effects
Primary endpoint: steady employment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Expression of dystrophin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Concentration of MDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of thigh girth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Emergence from anaesthesia (EA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to extubation (TE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of endotracheal tube tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cohen‐Mansfield Agitation Inventory score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Readmission events within 2 years
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mortality related to incorrect helmet use
Endpoint domain: Mortality/survival
Primary endpoint: Seroconversion rates of neutralizing antibodies (NAb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean titers (GMTs) of anti-S and anti-N antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in social and recreational activities
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Diclofenac concentration in synovial fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: obstetrical providers' recall of details
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mGFR at Day 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: mGFR at twelve months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: VFH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acceptance of referral to quitline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: use of quitline services
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD TLR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Stump leakage rate
Endpoint domain: Adverse events/effects
Primary endpoint: Anastomotic stricture (AS) rate
Endpoint domain: Adverse events/effects
Primary endpoint: Mean reduction in DHI-S score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: total wrist-hand motor score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensorimotor score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of routine donor milk use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle soreness score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of enlarged facial pores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: OPLP (Oropharyngeal Leak Pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSA in RLDP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: GV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean awake systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean asleep systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of valid BP readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stop-signal reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Composite of bleeding or thromboembolic events
Endpoint domain: Adverse events/effects
Primary endpoint: 24-h ambulatory bPP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: rAI changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: First time for analgesic request
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPI Interference score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GCPS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: health-related quality of life (Physical Component Summary)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Recurrent arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intended e-cigarette use in future quit attempts
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cvBRS up-up (vagal activation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cvBRS down-down (vagal withdrawal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average cure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scapular notching rates
Endpoint domain: Adverse events/effects
Primary endpoint: Performance scores in cVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to achieve stereovision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum contraceptive uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average pain scores 1 yr postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall radiation exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial stiffness (AoPWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: discharge to a postacute care facility
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: cost-effectiveness of mirtazapine
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Lung cancer frequency
Endpoint domain: Mortality/survival
Primary endpoint: Nodule volume as a predictor of lung cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Relative risk of lung cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reduction in Monthly Headache Days (MHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of experiencing a second myocardial infarction (MI)
Endpoint domain: Mortality/survival
Primary endpoint: Risk of experiencing a second stroke
Endpoint domain: Mortality/survival
Primary endpoint: Normalization of SDM conversation tool
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: freedom from migraine headache pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: freedom from associated symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: achieving normal function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Area under the curve (AUC) for MVI prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical jump height improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to chemotherapy (TTC)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pessimism as a predictive symptom
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incidence of single LN station metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: BFlh fascicle length (FL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Eccentric knee flexor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peak velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Spatial consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Severity of Early Childhood Caries (ECC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental eHealth Literacy (eHEALS scores)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge about asthma management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants remaining in remission
Endpoint domain: Mortality/survival
Primary endpoint: Physiological comfort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Good Knowledge on Medicines
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anti-Mullerian hormone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Battery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Download time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRQ-total
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CRQ-emotion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PROMIS-fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Improvements in parenting stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: overall clinical success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient recall rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: LCQ total score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: fat graft viability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Phosphorylation of mTORSer2448
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased LC3BII protein content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of students meeting mental health caseness criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of exercise sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant perceived benefits
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Level of confidence in performing pericardiocentesis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Learner satisfaction with Centesys
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Successful insertion of a pericardial drain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: mean internal rotation of the reconstructed knees
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Drop-out rates in pain management
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Occurrence of major errors during tasks
Endpoint domain: Adverse events/effects
Primary endpoint: Mean time in range 70-180 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGM-measured percent time <54 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IRC-assessed Progression-Free Survival (PFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IRC-assessed Overall Response Rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Monthly Migraine Days (MMDs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Chronic Post-Surgical Pain (CPSP) at three months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Chronic Post-Surgical Pain (CPSP) at six months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to resolution of clinical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite of cardiovascular death, myocardial infarction, stroke, hospitalization for unstable angina, or coronary revascularization
Endpoint domain: Mortality/survival
Primary endpoint: knowledge
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: symptoms
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Ease of use of CPI technology
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in pressure relief provision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Influence of device on care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Time to visualize the glottis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of external laryngeal manipulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to non-breast cancer recurrence (TTNBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean total intraoperative fentanyl dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to the first analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical diagnosis of atopic dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of doctor‐diagnosed food allergy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRT compliance rate
Endpoint domain: Resource use
Primary endpoint: ischemic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity and duration of adenoiditis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness rated as recovery by parents/legal representatives
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CK activity in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceived usefulness of the blog to improve dietary habits
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive rate of ICA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HADS score before ICA
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Need for re-anesthesia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Medication use for headaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discontinuation of medications for depression and anxiety/panic
Endpoint domain: Adverse events/effects
Primary endpoint: Prescription filling for antianxiety and antidepressant medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in Staphylococcus aureus nasal colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cmax GMR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0‐t GMR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0‐∞ GMR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glaucoma prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: N-terminal propeptide of procollagen type I (P1NP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: C-telopeptide of type I collagen (CTX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FB successful completion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to fully alert
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hair TFV levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viremia frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Clinical anxiety at follow-up
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Serum PM20D1 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Circulating levels of C18:1‐Leu and C18:1‐Phe
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Parameters of adiposity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Albumin loss per session
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of serum IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Clearance of lung infiltrates as measured by chest CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in nimodipine prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Estimated annual net cost benefit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in P. aeruginosa density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement in Quality-of-life-Bronchiectasis Respiratory Symptom Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean duration of PIC procedure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Functional outcome score at 3 months postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total closure rate of the great saphenous vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Paresthesia
Endpoint domain: Adverse events/effects
Primary endpoint: Reductions in IBS symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical performance competency scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: learner satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 6-month progression-free rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Score Approval Rates (OSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0–168 h of somapacitan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0–168 h of IGF-I
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: open eyes balance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fall efficacy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Overall success rate of arthrocentesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First-pass success rate of arthrocentesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of attempts for arthrocentesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Disease Progression (TTD)
Endpoint domain: Mortality/survival
Primary endpoint: Time to half GES (T1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Fasting gastric volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: post-PCI corrected TIMI frame count (CTFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Opioid underuse for dyspnoea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid underuse for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid underuse for both symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes